Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Seng G, Lim"'
Publikováno v:
Clinical & Laboratory Haematology. 12:237-245
Summary HIV associated thrombocytopenia occurs in 5–10% of asymptomatic individuals, and 25–45% of people with AIDS. A variety of treatments are available but the inherited bleeding disorder in addition to the thrombocytopenia makes management in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::799eaa1d604813b989727ba2668360f6
https://doi.org/10.1111/j.1365-2257.1990.tb00033.x
https://doi.org/10.1111/j.1365-2257.1990.tb00033.x
Autor:
Peter B. A. Kernoff, Gillian Tilsed, Paul D. Griffiths, Seng G. Lim, Christine A. Lee, Heather Charman
Publikováno v:
British Journal of Haematology. 78:398-402
Summary. Stored sera from 28 patients with inherited coagulation disorders who had developed non-A non-B hepatitis (NANBH) following a first exposure to clotting factor concentrates and 15 similar, but unmatched, patients who had received blood produ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25792d62dd45d915a9dfaa0b81c075bd
https://doi.org/10.1111/j.1365-2141.1991.tb04454.x
https://doi.org/10.1111/j.1365-2141.1991.tb04454.x
Autor:
Shu C, Li, Siew C, Ong, Sien C, Ong, Seng G, Lim, Khay G, Yeoh, Kai S, Kwong, Vivian, Lee, Winnie, Lee, Joseph, Lau, Ian, Wong, Nelson, Kung, Wai T, Leung, Henry L Y, Chan, Francis K L, Chan, Joseph J Y, Sung, Kenneth K C, Lee
Publikováno v:
Journal of clinical gastroenterology. 38(10 Suppl 3)
GOALS: To estimate and compare the direct medical cost in the management of chronic hepatitis B (CHB) infection and its complications from the perspective of public health organizations in Hong Kong and Singapore. BACKGROUND: Hong Kong and Singapore
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2de8348e50e9eb7fed70fa6712453938
https://pubmed.ncbi.nlm.nih.gov/15602161
https://pubmed.ncbi.nlm.nih.gov/15602161
Publikováno v:
Clinical and laboratory haematology. 12(4)
Summary. Twenty haemophiliacs (17 CDC group IV and 3 CDC group II) were treated with zidovudine for a median of 37 weeks (range 10–66). Eight (40%) tolerated zidovudine without a dose change. Two patients died and five patients (29%) developed oppo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e9a761586913c1970f4284b7797d7cb
https://pubmed.ncbi.nlm.nih.gov/2081377
https://pubmed.ncbi.nlm.nih.gov/2081377